NO764039L - - Google Patents

Info

Publication number
NO764039L
NO764039L NO764039A NO764039A NO764039L NO 764039 L NO764039 L NO 764039L NO 764039 A NO764039 A NO 764039A NO 764039 A NO764039 A NO 764039A NO 764039 L NO764039 L NO 764039L
Authority
NO
Norway
Prior art keywords
formula
hydrogen
stands
compounds
group
Prior art date
Application number
NO764039A
Other languages
English (en)
Norwegian (no)
Inventor
P Neumann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1571675A external-priority patent/CH605934A5/de
Priority claimed from CH1664575A external-priority patent/CH605858A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO764039L publication Critical patent/NO764039L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO764039A 1975-12-03 1976-11-25 NO764039L (enExample)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1571675A CH605934A5 (en) 1975-12-03 1975-12-03 Myotonolytic oxazolinyl- and thiazolinyl-amino-indazole derivs.
CH1664575A CH605858A5 (en) 1975-12-22 1975-12-22 Myotonolytic oxazolinyl- and thiazolinyl-amino-indazole derivs.
CH927976 1976-07-20
CH931276 1976-07-21

Publications (1)

Publication Number Publication Date
NO764039L true NO764039L (enExample) 1977-06-06

Family

ID=27429211

Family Applications (1)

Application Number Title Priority Date Filing Date
NO764039A NO764039L (enExample) 1975-12-03 1976-11-25

Country Status (20)

Country Link
US (1) US4086353A (enExample)
JP (1) JPS5268177A (enExample)
AU (1) AU510820B2 (enExample)
BE (1) BE848962A (enExample)
CA (1) CA1082714A (enExample)
DE (1) DE2653005A1 (enExample)
DK (1) DK528976A (enExample)
ES (1) ES453861A1 (enExample)
FI (1) FI763385A7 (enExample)
FR (1) FR2333504A1 (enExample)
GB (1) GB1564327A (enExample)
IE (1) IE44316B1 (enExample)
IL (1) IL51028A (enExample)
NL (1) NL7613317A (enExample)
NO (1) NO764039L (enExample)
NZ (1) NZ182779A (enExample)
PH (1) PH12642A (enExample)
PT (1) PT65918B (enExample)
SE (1) SE424553B (enExample)
YU (1) YU293876A (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982000824A1 (en) * 1980-09-05 1982-03-18 Geissmann F 1h and 2h indazol derivatives and medicaments containing them
KR20040047869A (ko) * 2001-09-26 2004-06-05 파마시아 이탈리아 에스.피.에이. 키나제 억제제로서 활성인 아미노인다졸 유도체, 이의제조방법 및 이를 함유하는 약제학적 조성물
SE0402763D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Nitro indazole derivatives
SE0402762D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Indazole sulphonamide derivatives
DE602006021645D1 (de) * 2005-11-15 2011-06-09 Array Biopharma Inc Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten
CA2633584A1 (en) * 2005-12-20 2007-07-05 Takeda Pharmaceutical Company Limited Glucokinase activators
EP2178870B1 (en) * 2007-08-17 2018-09-19 LG Chem, Ltd. Indole and indazole compounds as an inhibitor of cellular necrosis
KR101098583B1 (ko) * 2008-01-04 2011-12-26 주식회사 엘지생명과학 세포, 조직 및 장기 보존 효과를 갖는 인돌 및 인다졸 유도체
WO2013077579A1 (ko) * 2011-11-25 2013-05-30 가톨릭대학교 산학협력단 안과 질환의 예방 및 치료용 약학 조성물
WO2016115282A1 (en) 2015-01-13 2016-07-21 Vanderbilt University Benzoisoxazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
WO2016115272A1 (en) 2015-01-13 2016-07-21 Vanderbilt University Benzothiazole and benzisothiazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
WO2016123629A1 (en) 2015-01-30 2016-08-04 Vanderbilt University Indazole and azaindazole substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759903A (en) * 1971-07-28 1973-09-18 Squibb & Sons Inc Thiazolinyl and thiazinyl derivatives of indazoles

Also Published As

Publication number Publication date
JPS5268177A (en) 1977-06-06
IE44316L (en) 1977-06-03
AU510820B2 (en) 1980-07-17
DK528976A (da) 1977-06-04
NZ182779A (en) 1979-08-31
SE7613195L (sv) 1977-06-04
ES453861A1 (es) 1978-03-01
FI763385A7 (enExample) 1977-06-04
IL51028A (en) 1980-06-30
BE848962A (fr) 1977-06-01
PT65918B (fr) 1978-07-05
SE424553B (sv) 1982-07-26
US4086353A (en) 1978-04-25
PH12642A (en) 1979-07-11
GB1564327A (en) 1980-04-10
CA1082714A (en) 1980-07-29
IL51028A0 (en) 1977-02-28
FR2333504B1 (enExample) 1980-08-29
PT65918A (fr) 1977-01-01
DE2653005A1 (de) 1977-06-08
AU2025276A (en) 1978-06-08
NL7613317A (nl) 1977-06-07
FR2333504A1 (fr) 1977-07-01
IE44316B1 (en) 1981-10-21
YU293876A (en) 1982-05-31

Similar Documents

Publication Publication Date Title
NO120426B (enExample)
SU493966A3 (ru) Способ получени производных 4-/2имидазолин-2-иламино/-2,1,3-бензотиадиазола
NO762661L (enExample)
US4076709A (en) Thienothiazines
SU557758A3 (ru) Способ получени 4-азабензимидазолов или их солей
NO136360B (enExample)
IE41457B1 (en) Thienothiazine derivatives
SU566524A3 (ru) Способ получени производных пиридо(1,2-а)-пиримидина или их солей
US4061647A (en) Thiazolidine derivatives
Zinnes et al. 1, 2-Benzothiazines. 6. 3-Carbamoyl-4-hydroxy-2H-1, 2-benzothiazine 1, 1-dioxides as antiinflammatory agents
US3847934A (en) 7-(imidazolinyl-(2)-amino)-indazoles
NO845169L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater
GB1564327A (en) Indazole derivates
NO124430B (enExample)
NO814468L (no) Tiazolinderivater, fremgangsmaate til deres fremstilling, deres anvendelse samt farmasoeytiske preparater paa basis av disse forbindelser
NO811667L (no) Fremgangsmaate ved fremstilling av substituerte pyrazinyl-1,2,4-oxadiazoler
US4090020A (en) Thienothiazine derivatives
NO803160L (no) Pyrimidin-derivater.
US3244723A (en) Certain 4-aminothiazole compounds and their preparation
NO130329B (enExample)
US2839529A (en) Isothiazole compounds
SU419028A3 (ru) Способ получения 2-
DK156059B (da) Analogifremgangsmaade til fremstilling af guanidinderivater
NO762821L (enExample)
NO162156B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tiadiazinonderivater